Market revenue in 2023 | USD 119.6 million |
Market revenue in 2030 | USD 171.0 million |
Growth rate | 5.2% (CAGR from 2023 to 2030) |
Largest segment | Molecular diagnostics |
Fastest growing segment | Immunoassays |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Immunoassays, Hematology and Coagulation, Molecular Diagnostics, Microbiology, Clinical Chemistry, Histology/Cytology, Flow Cytometry, Mass Spectroscopy |
Key market players worldwide | Quest Diagnostics Inc, 23andMe Holding Co Class A, Abbott Laboratories, Guardant Health Inc, NeoGenomics, Siemens Healthineers AG ADR, Qiagen NV, Illumina Inc, Roche Holding AG ADR |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to laboratory developed tests market will help companies and investors design strategic landscapes.
Molecular diagnostics was the largest segment with a revenue share of 22.49% in 2023. Horizon Databook has segmented the UAE laboratory developed tests market based on immunoassays, hematology and coagulation, molecular diagnostics, microbiology, clinical chemistry, histology/cytology, flow cytometry, mass spectroscopy covering the revenue growth of each sub-segment from 2018 to 2030.
The UAE LDT market is expected to show a significant growth rate during the forecast period. The growth of this market can be attributed to increasing government initiatives, such as launch of awareness programs and funding for research & development.
For instance, in July 2017, the American Association for Clinical Chemistry (AACC) announced that it would launch a new AACC Middle East in Abu Dhabi, UAE, to provide educational programs in the field of clinical testing. The AACC Middle East is focused on promoting the advancement of clinical laboratory sciences, and its activities include supporting the development & use of LDTs in the region.
The organization may provide educational & training resources for laboratory professionals to enhance their knowledge & expertise in the use of LDTs, and may also advocate for the implementation of appropriate regulations & standards for LDTs. In addition, the AACC Middle East may work with regulatory agencies and healthcare organizations to promote the use of high-quality LDTs.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE laboratory developed tests market , including forecasts for subscribers. This country databook contains high-level insights into UAE laboratory developed tests market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account